Clinigen makes Japanese acquisition
Clinigen, the Burton pharmaceutical and services company, has bought International Medical Management Corporation (IMMC), Japan's largest supplier of unlicensed medicines, for an undisclosed sum.
The acquisition will add to Clinigen's existing footprint in the country following the launch of its Japanese business in October 2016.
IMMC, established in 2006, operates throughout Japan in sectors including niche vaccine, oncology and IVF. It currently has relationships with more than 850 hospitals and clinics, which will now be able... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
